Jereme M Sylvain, the EVP of $DXCM, sold 4,824 shares of the company on 09-02-2025 for an estimated $357,796. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.9% of their shares of this class of stock. Following this trade, they now own 118,657 shares of this class of $DXCM stock.
$DXCM Insider Trading Activity
$DXCM insiders have traded $DXCM stock on the open market 24 times in the past 6 months. Of those trades, 0 have been purchases and 24 have been sales.
Here’s a breakdown of recent trading of $DXCM stock by insiders over the last 6 months:
- KEVIN R SAYER (Chairman, CEO & President) sold 32,498 shares for an estimated $2,287,212
- MICHAEL JON BROWN (EVP, Chief Legal Officer) has made 0 purchases and 5 sales selling 24,500 shares for an estimated $1,882,350.
- JEREME M SYLVAIN (EVP, Chief Financal Officer) has made 0 purchases and 5 sales selling 23,825 shares for an estimated $1,719,257.
- SADIE STERN (EVP, Chief HR Officer) has made 0 purchases and 4 sales selling 20,292 shares for an estimated $1,568,043.
- JACOB STEVEN LEACH (EVP, Chief Operating Officer) sold 14,076 shares for an estimated $990,670
- MARK G FOLETTA has made 0 purchases and 5 sales selling 8,250 shares for an estimated $685,724.
- NICHOLAS AUGUSTINOS has made 0 purchases and 2 sales selling 6,290 shares for an estimated $517,906.
- BRIDGETTE P HELLER sold 352 shares for an estimated $24,756
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DXCM Hedge Fund Activity
We have seen 457 institutional investors add shares of $DXCM stock to their portfolio, and 533 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 6,630,079 shares (-55.1%) from their portfolio in Q2 2025, for an estimated $578,739,595
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 3,410,858 shares (+106.8%) to their portfolio in Q2 2025, for an estimated $297,733,794
- MARSHALL WACE, LLP added 2,762,504 shares (+260.7%) to their portfolio in Q2 2025, for an estimated $241,138,974
- BAILLIE GIFFORD & CO added 2,525,365 shares (+17.8%) to their portfolio in Q2 2025, for an estimated $220,439,110
- JPMORGAN CHASE & CO added 2,013,099 shares (+48.6%) to their portfolio in Q2 2025, for an estimated $175,723,411
- CAPITAL WORLD INVESTORS removed 1,686,334 shares (-54.9%) from their portfolio in Q2 2025, for an estimated $147,200,094
- FEDERATED HERMES, INC. added 1,638,407 shares (+82.1%) to their portfolio in Q2 2025, for an estimated $143,016,547
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DXCM Congressional Stock Trading
Members of Congress have traded $DXCM stock 5 times in the past 6 months. Of those trades, 2 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $DXCM stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 05/15 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE JEFFERSON SHREVE has traded it 3 times. They made 1 purchase worth up to $50,000 on 05/08 and 2 sales worth up to $100,000 on 05/12, 04/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$DXCM Analyst Ratings
Wall Street analysts have issued reports on $DXCM in the last several months. We have seen 11 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Argus Research issued a "Buy" rating on 08/21/2025
- Canaccord Genuity issued a "Buy" rating on 08/01/2025
- Oppenheimer issued a "Outperform" rating on 07/31/2025
- UBS issued a "Buy" rating on 07/31/2025
- Raymond James issued a "Strong Buy" rating on 07/31/2025
- Piper Sandler issued a "Overweight" rating on 07/31/2025
- Mizuho issued a "Outperform" rating on 07/16/2025
To track analyst ratings and price targets for $DXCM, check out Quiver Quantitative's $DXCM forecast page.
$DXCM Price Targets
Multiple analysts have issued price targets for $DXCM recently. We have seen 13 analysts offer price targets for $DXCM in the last 6 months, with a median target of $102.0.
Here are some recent targets:
- Steve Silver from Argus Research set a target price of $100.0 on 08/21/2025
- William Plovanic from Canaccord Genuity set a target price of $106.0 on 08/01/2025
- Matt O'Brien from Piper Sandler set a target price of $100.0 on 07/31/2025
- Jayson Bedford from Raymond James set a target price of $102.0 on 07/31/2025
- Steven Lichtman from Oppenheimer set a target price of $102.0 on 07/31/2025
- Danielle Antalffy from UBS set a target price of $106.0 on 07/31/2025
- Matt Miksic from Barclays set a target price of $98.0 on 07/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
